Company page

Annexon, Inc.

Annexon, Inc. is a public company traded under the ticker ANNX in the American market. The company has a market capitalization of approximately $855.26 million. Annexon focuses on developing therapies for neurodegenerative diseases and other serious conditions.

ANNX:NASDAQUpdated August 28, 2026
Annexon, Inc. logo
Ticker
ANNX:NASDAQ
Asset type
Stock
Market cap
$942.2M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
NASDAQ
Currency
USD